Viewing Study NCT04485702


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2025-12-26 @ 2:34 AM
Study NCT ID: NCT04485702
Status: COMPLETED
Last Update Posted: 2021-02-23
First Post: 2020-07-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 1 Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual) and IV Midazolam or Ketamine
Sponsor: Melt Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module